BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०१३
०.००%
(०.००) 1D
अक्टोबर २२, १६:१०:३० GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
४.३१ करोड
Avg. vol.
७९.१२ लाख
Volume
३०.५७ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
४.३१ करोड
Avg. vol.
७९.१२ लाख
Volume
३०.५७ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
Benzinga
·
२२ मिनेट पहिले
Nasdaq Surges Over 1% As SpaceX Shares Gain: Investor Sentiment Improves, But Greed Index Remains In ‘Fea
Simply Wall Street
·
४१ मिनेट पहिले
3 Founder Led Stocks To Watch With Up To 49% Profit Margin
Yahoo Finance
·
१ घण्टा पहिले
RKLB Is Among Nasdaq’s Top 5 Losers So Far This Month, Yet Analysts See 90% Upside — Can Neutron Justify Its SpaceX Premium?
Investor's Business Daily
·
५ घण्टा पहिले
Futures Fall; Meta, Tesla Lead Big Earnings Late
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd